Everything you care about in one place
Follow feeds: blogs, news, RSS and more. An effortless way to read and digest content of your choice.
Get Feederema.europa.eu
Human medicines: European public assessment reports (EPARs)
Get the latest updates from Human medicines: European public assessment reports (EPARs) directly as they happen.
Follow now 282 followers
Latest posts
Last updated 1 day ago
Human medicines European public assessment report (EPAR): Osvyrti, denosumab, Date of authorisation: 26/05/2025, Revision: 1, Status: Authorised
1 day ago
Human medicines European public assessment report (EPAR): Osvyrti, denosumab, Date of authorisation...
Human medicines European public assessment report (EPAR): Zemcelpro, allogeneic umbilical cord-derived CD34- cells, non-expanded,dorocubicel, Date of authorisation: 25/08/2025, Status: Authorised
1 day ago
Human medicines European public assessment report (EPAR): Zemcelpro, allogeneic umbilical cord-derived CD34-...
Human medicines European public assessment report (EPAR): Avastin, bevacizumab, Date of authorisation: 12/01/2005, Revision: 67, Status: Authorised
4 days ago
Human medicines European public assessment report (EPAR): Avastin, bevacizumab, Date of authorisation...
Human medicines European public assessment report (EPAR): Attrogy, diflunisal, Date of authorisation: 17/07/2025, Revision: 1, Status: Authorised
4 days ago
Human medicines European public assessment report (EPAR): Attrogy, diflunisal, Date of authorisation...
Human medicines European public assessment report (EPAR): Rotarix, rotavirus vaccine, live, Date of authorisation: 21/02/2006, Revision: 44, Status: Authorised
4 days ago
Human medicines European public assessment report (EPAR): Rotarix, rotavirus vaccine, live, Date...
Human medicines European public assessment report (EPAR): Olumiant, baricitinib, Date of authorisation: 13/02/2017, Revision: 24, Status: Authorised
4 days ago
Human medicines European public assessment report (EPAR): Olumiant, baricitinib, Date of authorisation...
Human medicines European public assessment report (EPAR): Minjuvi, tafasitamab, Date of authorisation: 26/08/2021, Revision: 10, Status: Authorised
4 days ago
Human medicines European public assessment report (EPAR): Minjuvi, tafasitamab, Date of authorisation...
Human medicines European public assessment report (EPAR): Replagal, agalsidase alfa, Date of authorisation: 03/08/2001, Revision: 30, Status: Authorised
4 days ago
Human medicines European public assessment report (EPAR): Replagal, agalsidase alfa, Date of...
Human medicines European public assessment report (EPAR): Pregabalin Viatris (previously Pregabalin Mylan), pregabalin, Date of authorisation: 24/06/2015, Revision: 23, Status: Authorised
5 days ago
Human medicines European public assessment report (EPAR): Pregabalin Viatris (previously Pregabalin Mylan)...
Human medicines European public assessment report (EPAR): Leflunomide medac, leflunomide, Date of authorisation: 27/07/2010, Revision: 25, Status: Authorised
5 days ago
Human medicines European public assessment report (EPAR): Leflunomide medac, leflunomide, Date of...
Human medicines European public assessment report (EPAR): Yargesa, miglustat, Date of authorisation: 22/03/2017, Revision: 7, Status: Authorised
5 days ago
Human medicines European public assessment report (EPAR): Yargesa, miglustat, Date of authorisation...
Human medicines European public assessment report (EPAR): Simulect, basiliximab, Date of authorisation: 09/10/1998, Revision: 30, Status: Authorised
5 days ago
Human medicines European public assessment report (EPAR): Simulect, basiliximab, Date of authorisation...